Strides Pharma International Limited, a wholly-owned subsidiary of Strides Pharma Science Limited, has entered into a Share Transfer Agreement on June 16, 2025, to divest its 100% shareholding in Strides CIS Limited, Cyprus to a third party.
The divestment is part of right-sizing group entities and eliminating dormant entities.
Strides CIS Limited was a dormant company with negligible net worth as compared to the consolidated Networth of Strides Pharma Science as of March 31, 2025.
The consideration received from the sale is USD 100 (₹8,341 approximately).
The buyers are Mr. Sarvesh Bhargava and his spouse Mrs. Ranjana Bhargava, each acquiring a 50% stake.
Sarvesh Bhargava is the CEO & Managing Director of M. Biotech Limited, a UK based Pharma company.
The buyers are not related to the Promoter/ Promoter Group/ Group Companies of Strides Pharma Science Limited.